Ioversol
Market - Global Industry Insights, Size, Share, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Ioversol is a white to off-white
crystalline powder having a crystalline sulfide-like odor. It is a non-ionic
radiological contrast agent that is included in a group of drugs known as
radiopaque contrast agents. It contains iodine, a substance that has the
ability to absorb x-rays. Ioversol allows the blood vessels, organs and others
non-bony tissues of the body to be seen more clearly during a CT scan or similar
radiologic (x-ray) examination. Ioversol is injected into an artery or vein
through an IV (Intravenous). The uniqueness and versatility of ioversol has
also expanded its use in magnetic resonance imaging and ultrasound scattering.
Ioversol is also used for the treatment, control, prevention and improvement of
heart disorders, brain disorders and blood vessel disorders. Ioversol is
generally not given on dosage. However, in some cases, a dosage of ioversol is
given to the patient based on the condition he/she is being treated, how
patient respond to this drug, patient’s weight, height, age, and gender, etc.
CMI predicts the global Ioversal market to grow at a healthy growth rate over
the forecast period owing to an escalating demand for ioversol among consumers
and clinics.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/386
The market for ioversol is mainly
driven by the robustly growing imaging and x-ray market. Rising prevalence of
cardiovascular disorders is giving pace to x-ray industry and thus the ioversol
market. Bone-related challenges and diseases, rising accidents and kidney
related problems are the key drivers for growth of the ioversol industry.
Another factor boosting growth of the global ioversol market is the growing
geriatric population which are more prone to orthopedic disorders than the
younger demographics. However, factors such as allergic reaction by use of
ioversol, swelling, difficulty in breathing, rapid weight gain, joint pain or
stiffness, muscle pain or weakness, nausea, sweating, etc. may hamper the
demand for ioversol in the near future. Advancements in the computed tomography
(CT) technology can prove to be a lucrative factor for market growth over the
forecast period.
Ioversol 64% Injectable Solution,
made from 636 mg of ioversol with 3.6 mg of tromethamine as a buffer and 0.2 mg
of calcium disodium as a stabilizer, is the most commonly used ioversol type
primarily owing to high scope of application, ease of use and low cost. On the
basis of application, the x-ray segment is forecast to grow at the fastest rate
over the forecast period owing to the growing demand for ioversol in
angiography, tomography, urography and others.
Market Outlook - Asia Pacific is
expected to be the most lucrative region for the key players operating in the
global Ioversol market
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/ioversol-market-386
On the basis of geography, the
global ioversol market is segmented into North America, Latin America, Europe,
Middle East, Asia-Pacific and Africa. Market of Ioversol is anticipated to
witness a high demand in the Asia-Pacific region owing to the constant rise in
pharmaceutical spending, increasing awareness regarding the use of ioversol and
the growing population base, particularly in countries such as China and India.
North America is currently the second largest market for ioversol and is
expected to grow at an above average growth rate over the forecast period.
Europe is expected to showcase a sluggish growth during the forecast period
owing to the maturing pharmaceutical industry.
The key players profiled in the
global ioversol market are Liebel-Flarsheim Company LLC, Guerbet, Jiangsu
Hengrui Medicine Co., Mallinckrodt Pharmaceuticals, Ultraject, China Resources
Pharmaceutical Co., HB Ocean, Changzhou Highassay Chemical Co., Ltd., and
various others. Major players in the market are focused on product launches and
organic growth by means of mergers and acquisitions.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/386
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment